Abstract
Telomerase is an attractive target for anti-tumor therapy as it is almost universally expressed in cancer cells. Here, we show that treatment with a telomere-targeting drug, 6-thio-2'-deoxyguanosine (6-thio-dG), leads to tumor regression through innate and adaptive immune-dependent responses in syngeneic and humanized mouse models of telomerase-expressing cancers. 6-thio-dG treatment causes telomere-associated DNA damages that are sensed by dendritic cells (DCs) and activates the host cytosolic DNA sensing STING/interferon I pathway, resulting in enhanced cross-priming capacity of DCs and tumor-specific CD8+ T cell activation. Moreover, 6-thio-dG overcomes resistance to checkpoint blockade in advanced cancer models. Our results unveil how telomere stress increases innate sensing and adaptive anti-tumor immunity and provide strong rationales for combining telomere-targeting therapy with immunotherapy.
Keywords:
6-thio-dG; DNA damage; PD-1/PD-L1; STING; anti-tumor immunity; checkpoint blockade; immunotherapy; innate sensing; telomerase; telomere-targeting therapy.
Copyright © 2020 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adaptive Immunity / drug effects
-
Animals
-
CD8-Positive T-Lymphocytes / drug effects
-
CD8-Positive T-Lymphocytes / immunology
-
CD8-Positive T-Lymphocytes / metabolism
-
Cell Line, Tumor
-
Deoxyguanosine / analogs & derivatives*
-
Deoxyguanosine / pharmacology
-
Deoxyguanosine / therapeutic use
-
HCT116 Cells
-
Humans
-
Immunity, Innate / drug effects
-
Membrane Proteins / genetics
-
Membrane Proteins / immunology*
-
Membrane Proteins / metabolism
-
Mice, Inbred BALB C
-
Mice, Inbred C57BL
-
Mice, Knockout
-
Neoplasms / drug therapy*
-
Neoplasms / genetics
-
Neoplasms / immunology
-
Neoplasms, Experimental / drug therapy
-
Neoplasms, Experimental / genetics
-
Neoplasms, Experimental / immunology
-
Signal Transduction / drug effects
-
Signal Transduction / genetics
-
Signal Transduction / immunology
-
Telomerase / antagonists & inhibitors*
-
Telomerase / metabolism
-
Telomere / enzymology
-
Telomere / genetics*
-
Thionucleosides / pharmacology*
-
Thionucleosides / therapeutic use
-
Tumor Burden / drug effects
-
Tumor Burden / genetics
-
Tumor Burden / immunology
Substances
-
Membrane Proteins
-
STING1 protein, human
-
Thionucleosides
-
alpha-2'-deoxythioguanosine
-
Telomerase
-
Deoxyguanosine